Table 2.
Procedural, clinical, and volumetrical data after completed ALPPS
Variable | Rescue ALPPS (n = 11) |
---|---|
Operating time stage 1, min (range) | 282 (200–398) |
Bleeding during stage 1, ml (range) | 1500 (400–5600) |
Completed stage 2 | 11 |
R0-resection | 11 |
Complication (Clavien-Dindo) 3a | 4 |
Complication (Clavien-Dindo) ≥3b | 0 |
Fulfills Balzan criteria | 0 |
90-day mortality | 0 |
FLR after stage 2, ml (range) | 557 (395–619) |
FLR/BW ratio before stage 2, % (range) | 0.69 (0.59–0.81) |
sFLR before stage 2, % (range) | 31.2 (27.5–36) |
Growth of FLR between stage 1 and 2, % (range) | 61.8 (19.3–120) |
PK (INR) 1 day before stage 1 | 1.0 (0.9–1.1) |
PK (INR) 5 days after stage 1 | 1.2 (1.1–1.5) |
PK (INR) 5 days after stage 2 | 1.3 (1.2–1.8) |
Bilirubin 1 day before stage 1 | 6 (3–14) |
Bilirubin 5 days after stage 1 | 8 (6–22) |
Bilirubin 5 days after stage 2 | 17 (8–49) |
R0-resection radical resection with >1 mm margin, PK (INR) normal if <1.2, Bilirubin normal if <26 micromol/l